share_log
Reuters ·  May 3 16:09
ENDRA Life Sciences: Got Letter From Nasdaq That Co No Longer Meets Minimum Bid Price Requirement for Continued Listing on Nasdaq Capital Market
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment